Video

How PQA Identified the Need for New Opioid Measures

Lisa Hines, PharmD, vice president of Measurement and Operations at Pharmacy Quality Alliance (PQA), discusses the alliance's new opioid measures and how PQA identified the need for them during the PQA Annual Meeting in Baltimore, MD.

Lisa Hines, PharmD, vice president of Measurement and Operations at Pharmacy Quality Alliance (PQA), discusses the alliance's new opioid measures and how PQA identified the need for them during the PQA Annual Meeting in Baltimore, MD.

Lisa Hines, PharmD: So, we identified the gaps for these measures from the existing evidence showing that this was a problem, and that it was correlated with bad outcomes. And, also the measures are aligned with the CDC Opioid Prescribing Guidelines, and we just found that there was a gap for existing measurement, to address this epidemic.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Monoclonal antibodies are used to treat lung cancer. They are created in a lab and designed to target specific proteins on cancer cells, stopping them from growing and dividing.
Gene therapy in lung cancer (LC) - isometric view 3d illustration
© 2025 MJH Life Sciences

All rights reserved.